skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Datamonitor Healthcare

Understand Market Access Trends in the US, Europe and Emerging Markets

14 Nov 2022

Understand Market Access Trends in the US, Europe and Emerging Markets

This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.

Topic Drug Development Landscape Approvals Drug Review

Citeline

The State of Innovation in Europe

24 Oct 2022

state-of-innovation-in-europe-cover

Written by Daniel Chancellor, Thought Leadership and Consulting Director, Citeline

Citeline

The Clinical Trials Landscape

13 Oct 2022

annual_clinical_trials_round_up_2021cover

We witnessed all-time high trial volumes in 2021 and a new dominant force emerging in the clinical trial landscape. Learn more in our annual round-up.

Trialtrove

The Clinical Trials Landscape

06 Oct 2022

The Clinical Trials Landscape

Takes a deep dive into the clinical trial landscape in the Asia-Pacific (APAC) region over the past decade, from 2012 to 2021. APAC has become a hotspot for clinical trials, with trial activity trending upwards and eventually contributing almost half of the entire global clinical trial activity in 2021

Citeline

Pharma R&D Annual Review 2022: Navigating the Landscape

27 Jun 2022

Pharma R&D Annual Review 2022: Navigating the Landscape

Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Citeline

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

27 Jun 2022

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year. 

Citeline

Measuring the COVID Effect on Clinical Trials

27 Jun 2022

Measuring the COVID Effect on Clinical Trials

As the world begins its transition into a post-pandemic existence, it becomes possible to look back on the past two years and begin to quantify the effects that COVID-19 has brought.

Topic Clinical Trials

Citeline

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

27 Jun 2022

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.

Topic Clinical Trials

Pharma R&D Annual Review 2018

By Ian Lloyd 17 Jun 2022

Pharma R&D Annual Review 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Topic Research & Development

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: